Article

Erratum: Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19 (JAMA Internal Medicine (2021) 181:1 (41-51) DOI: 10.1001/jamainternmed.2020.6252)

JAMA Internal Medicine
DOI: 10.1001/jamainternmed.2021.0139
0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In the Original Investigation titled "Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19"1 that printed on January 4, 2021, the nonauthor collaborator names were omitted from the PubMed listing. The article has been corrected by adding Supplement 3 containing all names.

Cite

CITATION STYLE

APA

Erratum: Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19 (JAMA Internal Medicine (2021) 181:1 (41-51) DOI: 10.1001/jamainternmed.2020.6252). (2021, April 1). JAMA Internal Medicine. American Medical Association. https://doi.org/10.1001/jamainternmed.2021.0139

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free